https://ift.tt/2IVHF6y

The stock surged 14% to Rs 36.20 on the NSE after the company received USFDA approval for both its bulk drugs manufacturing facilities situated in Himachal Pradesh.

from Markets https://ift.tt/2K37tJL

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads